Seminars in Nephrology
Volume 25, Issue 5 , Pages 343-351 , September 2005

Endogenous Cardiac Glycosides: Hormones Using the Sodium Pump as Signal Transducer

  • Wilhelm Schoner

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dr. Wilhelm Schoner, Institut für Biochemie und Endokrinologie, Fachbereich Veterinärmedizin, Justus-Liebig-Universität Giessen, Frankfurter Str. 100, D-35392 Giessen, Germany.
    • ,
  • Georgios Scheiner-Bobis

References 

  1. Withering W: An account on the foxglove, and some of its medical uses with practical remark on dropsy and other diseases, in Robinson J (ed): An Account on the Foxglove, and Some of its Medical Uses With Practical Remark on Dropsy and Other Diseases. London, Paternoster-Row p 1785
  2. Schatzmann HJ . Herzglykoside als hemmstoffe für den aktiven kalium-und natriumtransport durch die erythrocytenmembran . Helv Physiol Pharmacol Acta . 1953;11:346–354
  3. Eisner DA , Smith TW . The Na-K pump and its effectors in cardiac muscle . In:  Fozzard HA ,  Haber E ,  Jennings RB ,  Katz AM ,  Morgan HE editor. ed 2. The Na-K pump and its effectors in cardiac muscle . 1: New York: Raven Press; 1992;p. 863–902
  4. Blaustein MP , Juhaszowa M , Golovina VA . The cellular mechanism of action of cardiotonic steroids (A new hypothesis) . Clin Exp Hypertens . 1998;20:691–703
  5. Juhaszova M , Blaustein MP . Na+ pump low and high ouabain affinity α subunit isoforms are differently distributed in cells . Proc Natl Acad Sci U S A . 1997;94:1800–1805
  6. Xie Z , Askari A . Na+/K+-ATPase as a signal inducer . Eur J Biochem . 2002;269:2434–2439
  7. Scheiner-Bobis G , Schoner W . A fresh facet for ouabain action . Nat Med . 2001;7:1288–1289
  8. Dahl LK , Knudsen KD , Heine M , et al.   Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats. Evidence for a circulating factor . J Exp Med . 1967;126:687–699
  9. deWardener HE , Clarkson EM . Concept of natriuretic hormone . Physiol Rev . 1985;65:658–759
  10. Blaustein MP . Sodium ions, calcium ions, blood pressure regulation and hypertension. A reassessment and a hypothesis . Am J Physiol . 1977;232:C167–C173
  11. Hamlyn JM , Ringel R , Schaeffer J , et al.   A circulating inhibitor of (Na+K)-ATPase associated with essential hypertension . Nature . 1982;300:650–652
  12. Blaustein MP . Physiological effects of endogenous ouabain. Control of intracellular Ca2+ stores and cell responsiveness . Am J Physiol . 1993;264:C1367–C1387
  13. Goto A , Yamada K . Ouabain-like factor . Curr Opin Nephrol Hypertens . 1998;7:189–196
  14. Hamlyn JM , Lu Z , Manunta P , et al.   Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain . Clin Exp Hypertens . 1998;20:523–533
  15. Schoner W . Endogenous cardiac glycosides, a new class of steroid hormones . Eur J Biochem . 2002;269:2440–2448
  16. Reichstein T . Cardenolid- und pregnanglykoside . Die Naturwissenschaften . 1967;3:53–76
  17. Höriger N , Zivanov D , Linde HH , et al.   Cardenolide hydrogen suberates and other bufadienolide hydrogen suberates in Ch’an Su . Helv Chim Acta . 1970;53:1993–2002
  18. Hamlyn JM , Blaustein MP , Bova S , et al.   Identification and characterization of a ouabain-like compound from human plasma . Proc Natl Acad Sci U S A . 1991;88:6259–6263
  19. Mathews WR , DuCharme DW , Hamlyn JM , et al.   Mass spectral characterization of an endogenous digitalis like factor from human plasma . Hypertension . 1991;17:930–935
  20. Schneider R , Wray V , Nimtz M , et al.   Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump . J Biol Chem . 1998;273:784–792
  21. Kawamura A , Guo J , Itagaki Y , et al.   On the structure of endogenous ouabain . Proc Natl Acad Sci U S A . 1999;96:6654–6659
  22. Komiyama Y , Nishimura N , Munakata M , et al.   Identification of endogenous ouabain in culture supernatant of PC12 cells . J Hypertens . 2001;19:229–236
  23. Hamlyn JM , Laredo J , Shah JR , et al.   11-Hydroxylation in the biosynthesis of endogenous ouabain (Multiple implications) . Ann N Y Acad Sci . 2003;986:685–693
  24. Kitano S , Morimoto S , Nishibe A , et al.   Exogenous ouabain is accumulated in the adrenals and mimics the kinetics of endogenous digitalis-like factor in rats . Hypertens Res . 1998;21:47–56
  25. Greef K , Wirth KE . Pharmacokinetics of strophanthin glycosides . Handbook Exp Pharmacol . 1981;56/II:57–85
  26. Boulanger BR , Lilly MP , Hamlyn JM , et al.   Ouabain is secreted by the adrenal gland of the awake dogs . Am J Physiol . 1993;264:E413–E419
  27. Masugi F , Ogihara T , Hasegawa T , et al.   Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma . J Hum Hypertens . 1988;2:17–20
  28. Li S-Q , Eim C , Kirch U , et al.   Bovine adrenals and hypothalamus are a major source of proscillaridin A- and ouabain-immunoreactivities . Life Sci . 1998;62:1023–1033
  29. Manunta P , Evans G , Hamilton BP , et al.   A new syndrome with elevated plasma ouabain and hypertension secondary to an adrenocortical tumor . J Hypertens . 1992;10:S27
  30. Komiyama Y , Nishimura N , Munakata M , et al.   Increases in plasma ouabain like immunoreactivity during surgical extirpation of pheochromocytoma . Hypertens Res . 1999;22:135–139
  31. Qazzaz HM , El-Masri MA , Valdes RJ . Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells . Endocrinology . 2000;141:3200–3209
  32. Perrin A , Brasmes B , Chambaz EM , et al.   Bovine adrenocortical cells in culture synthesize an ouabain-like compound . Mol Cell Endocrinol . 1997;126:7–15
  33. Doris PA , Hayward-Lester A , Bourne D , et al.   Ouabain production by cultured adrenal cells . Endocrinology . 1996;137:533–539
  34. Laredo J , Hamilton BP , Hamlyn JM . Ouabain is secreted by bovine adrenocortical cells . Endocrinology . 1994;135:794–797
  35. Lichtstein D , Steinitz M , Gati I , et al.   Biosynthesis of digitalis-compound in rat adrenal cells (Hydroxycholesterol as a precursor) . Life Sci . 1998;62:2109–2126
  36. Laredo J , Hamilton JP , Hamlyn JM . Secretion of endogenous ouabain from bovine adrenal cells. Role of zona glomerulosa and zona fasciculata . Biochem Biophys Res Commun . 1995;212:487–493
  37. Laredo J , Shah JR , Lu Z , et al.   Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenal cortical cells via angiotensin II receptors . Hypertension . 1997;29: 401-107
  38. Laredo J , Shah JR , Hamilton BP , et al.   Alpha-1 adrenergic receptors stimulate secretion of endogenous ouabain from human and bovine adrenocortical cells . In:  Taniguchi K ,  Kaya S editor. Alpha-1 Adrenergic Receptors Stimulate Secretion of Endogenous Ouabain From Human and Bovine Adrenocortical Cells . Amsterdam: Elsevier Science; 2000;p. 671–679
  39. De Angelis C , Haupert GT . Hypoxia triggers release of an endogenous inhibitor of Na+-K+-ATPase from midbrain and adrenal . Am J Physiol . 1998;274:F182–F188
  40. Paci A , Marrone O , Lenzi S , et al.   Endogenous digitalis like factors in obstructive sleep apnea . Hypertens Res . 2000;23(suppl):S87–S91
  41. Goto A , Ishiguro T , Yamada K , et al.   Isolation of an urinary digitalis-like factor indistinguishable from digoxin . Biochem Biophys Res Commun . 1990;173:1093–1101
  42. Goto A , Yamada K . Purification of endogenous digitalis-like factors from normal human urine . Clin Exp Hypertens . 1998;20:551–556
  43. Qazzaz HMAM , Goudy SL , Valdes RJ . Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue . J Biol Chem . 1996;271:8731–8737
  44. Qazzaz HM , Cao Z , Bolanowski DD , et al.   De novo biosynthesis and radiolabeling of mammalian digitalis-like factors . Clin Chem . 2004;50:612–620
  45. Qazzaz HMA , Lane AN , Valdes RJ . Structural identification of digoxin-like factors (DLIFs) using NMR spectroscopy . Clin Chem . 2003;49(suppl 6):A130
  46. Bagrov AY , Fedorova OV , Dmitrieva RI , et al.   Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction . Hypertension . 1998;31:1097–1103
  47. Lichtstein D , Gati I , Samuelov S , et al.   Identification of digitalis-like compounds in human cataractous lenses . Eur J Biochem . 1993;216:261–268
  48. Huang L , Li H , Xie Z . Ouabain-induced hypertrophy in cultured cardiac myocates is accompanied by changes in expression of several late response genes . J Mol Cell Cardiol . 1997;29:429–437
  49. Kometiani P , Li J , Gnudi L , et al.   Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases . J Biol Chem . 1998;273:15249–15256
  50. Haas M , Askari A , Xie Z . Involvement of Src and epidermal growth factor receptor in the signal transducing function of Na+/K+-ATPase . J Biol Chem . 2000;275:27832–27837
  51. Xie Z , Kometiani P , Liu J , et al.   Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes . J Biol Chem . 1999;274:19323–19328
  52. Mohammadi K , Kometiani P , Xie Z , et al.   Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2 . J Biol Chem . 2001;276:42050–42056
  53. Miyakawa-Naito A , Uhlén P , Lal M , et al.   Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-triphosphate receptor generates calcium oscillations . J Biol Chem . 2003;318:50355–50361
  54. Aizman O , Uhlén P , Lal M , et al.   Ouabain, a steroid hormone that signals with slow calcium oscillations . Proc Natl Acad Sci U S A . 2001;98:13420–13424
  55. Saunders R , Scheiner-Bobis G . Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump . Eur J Biochem . 2004;271:1054–1062
  56. Abramowitz J , Dai C , Hirschi KK , et al.   Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and rat vascular smooth muscle cell line, A7r5 . Circulation . 2003;108:3048–3053
  57. Aydemir-Koksoy A , Allen JC . Low concentrations of ouabain induce vascular smooth muscle cell proliferation . Cell Mol Biol (Noisy-le-grand) . 2001;47:341–345
  58. Golomb E , Hill MR , Brown RG , et al.   Ouabain enhances the mitogenic effect of serum in vascular smooth muscle cells . Am J Hypertens . 1994;7:69–74
  59. Arnon A , Hamlyn JM , Blaustein MP . Na+ entry via store-operated channels modulates Ca2+ signaling in arterial myocytes . Am J Physiol . 2000;278:C163–C173
  60. Godfraind T , Ghysel-Burton J . Independence of the positive inotropic effect of ouabain from the inhibition of the heart Na+/K+ pump . Proc Natl Acad Sci U S A . 1980;77:3067–3069
  61. Arnon A , Hamlyn JM , Blaustein MP . Ouabain augments Ca2+ transients in arterial smooth muscle without raising cytosolic Na+ . Am J Physiol . 2000;279:H679–H691
  62. Manunta P , Ferrandi M . Different effects of marinobufageinin and endogenous ouabain . J Hypertens . 2004;257:257–259
  63. Schoner W , Bauer N , Müller-Ehmsen J , et al.   Ouabain as a mammalian hormone . Ann N Y Acad Sci . 2003;986:678–684
  64. Goto A , Yamada K , Nagoshi H , et al.   Stress-induced elevation of ouabain like compound in rat plasma and adrenal . Hypertension . 1995;26:1173–1176
  65. Sopucleous A , Elmatzoglou I , Souvatzoglou A . Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent . J Endocrinol Invest . 2003;26:668–674
  66. Yamada K , Goto A , Omata M . Adrenocorticotropin-induced hypertension in rats (Role of ouabain-like compound) . Am J Hypertens . 1997;10:403–408
  67. Wang JG , Staessen JA , Messagio E , et al.   Salt, endogenous ouabain and blood pressure interactions in the general population . J Hypertens . 2003;2003:1475–1481
  68. Manunta P , Stella P , Rivera R , et al.   Left ventricular mass, stroke volume and ouabain-like factor in essential hypertension . Hypertension . 1999;34:450–456
  69. Pierdomenico SD , Bucci A , Manunta P , et al.   Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension . Am J Hypertens . 2001;14:44–50
  70. Erdmann E , Schoner W . Ouabain-receptor interactions in Na+ + K+-ATPase preparations. II. Effect of cations and nucleotides on rate constants and dissociation constants . Biochim Biophys Acta . 1973;330:302–315
  71. Kajimura S , Hirano T , Moriyama S , et al.   Changes in plasma concentrations of immunoreactive ouabain in the talipia in response to changing salinity (Is ouabain a hormone in fish) . Gen Comp Endocrinol . 2004;135:90–99
  72. Gottlieb SS , Rogowski AC , Weinberg M , et al.   Elevated concentrations of endogenous ouabain in patients with congestive heart failure . Circulation . 1992;86:420–425
  73. Manunta P , Messagio E , Ballabeni C , et al.   Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension . Hypertension . 2001;38:198–203
  74. Manunta P , Rogowski AC , Hamilton BP , et al.   Ouabain-induced hypertension in the rat (Relationships among plasma and tissue ouabain and blood pressure) . J Hypertens . 1994;12:549–560
  75. Pamnani MB , Chen S , Yuan CM , et al.   Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor in rats . Hypertension . 1994;23:I106–I109
  76. Veerasingham SJ , Leenen FH . Ouabain- and central sodium-induced hypertension depend on the ventral anteroventral third ventricle region . Am J Physiol . 1999;276:H63–H70
  77. Yuan CM , Manunta P , Hamlyn JM , et al.   Long-term ouabain administration produces hypertension in rats . Hypertension . 1993;22:178–187
  78. Manunta P , Hamilton BP , Hamlyn JM . Structure-activity relationship for hypertensinogenic activity of ouabain. Role of the sugar and lactone ring . Hypertension . 2001;37:472–477
  79. Manunta P , Hamilton J , Rogowski AC , et al.   Chronic hypertension induced by ouabain but not digoxin in the rat (Antihypertensive effect of digoxin and digitoxin) . Hypertens Res . 2000;23:S77–S85
  80. Adair CD , Buckalew V , Taylor K , et al.   Elevated endoxin-like factor complicating a multifetal second trimester pregnancy (Treatment with digoxin-binding immunoglobulin) . Am J Nephrol . 1996;16:529–531
  81. Goodlin RC . Antidigoxin antibodies in eclampsia . N Engl J Med . 1988;318:518–519
  82. Wang H , Yuan W-Q , Lu ZR . Differential regulation of the sodium pump alpha-subunit isoform gene by ouabain and digoxin in tissues of rats . Hypertens Res . 2000;23:S55–S60
  83. Schwinger RHG , Wang JG , Frank K , et al.   Reduced sodium pump α1, α3 and β1-isoform protein levels and Na/K-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure . Circulation . 1999;99:2105–22237
  84. Shamraj OI , Grupp IL , Grupp G , et al.   Characterization of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing hearts . Cardiovasc Res . 1993;72:2229–22237
  85. Huang BS , Harmsen E , Yu H , et al.   Brain ouabain-like activity and the sympathexcitatory and pressor effects of central sodium in rats . Circ Res . 1992;71:1059–1066
  86. Takahashi H , Matsuzawa M , Okabayashi H , et al.   Evidence for digitalis-like substance in the hypothalamopituitary axis in rats (Implications in the central cardiovascular regulation associated with excess intake of sodium) . Jpn Circ J . 1987;51:1199–1207
  87. Huang BS , Ganten D , Leenen FHH . Responses to central Na+ and ouabain are attenuated in transgenic rats deficient in brain angiotensogen . Hypertension . 2001;37:683–686
  88. Wang H , Huang BS , Leenen FHH . Brain sodium channel and ouabain like compounds mediate central aldosterone-induced hypertension . Am J Heart Circ Physiol . 2003;285:H2516–H2523
  89. Wang H , Leenen FHH . Brain sodium channels mediate increases in brain “ouabain” and blood pressure in Dahl S rats . Hypertension . 2002;40:96–100
  90. Zhao X , White R , Huang BS , et al.   High salt intake and the brain renin-angiotensin system in Dahl-sensitive rats . J Hypertens . 2001;19:89–98
  91. Ferrari P , Torielli L , Ferrandi M , et al.   PST 2238 (A new antihypertensive compound that antagonizes the long term pressor effect of ouabain) . J Pharmacol Exp Ther . 1998;285:83–94
  92. Quadri L , Bianchi G , Cerri A , et al.   17β-(3Furyl)-5β-androstane-3β-14β-17a-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action . J Med Chem . 1997;40:1561–1564
  93. Ferrari P , Ferrandi M , Tripoldi G , et al.   PST 2238 (A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension) . J Pharmacol Exp Ther . 1999;288:1074–1083
  94. Huang BS , Kudlac M , Kumarathasan R , et al.   Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation . Hypertension . 1999;34:733–738
  95. Gheorghiade M , Ferguson D . Digoxin (A neurohormone modulator in heart failure?) . Circulation . 1991;84:2181–2186
  96. Paganelli F , Maixent J-M , Gélisse R , et al.   Effect of digoxin on chemoreflex in patients with chronic heart failure . Cell Mol Biol . 2001;47:335–340
  97. Valdes R . Endogenous digoxin-immunoactive factor in human subjects . Fed Proc . 1985;44:2800–2805
  98. Fedorova OV , Bagrov AY . Inhibition of Na/K-ATPase from rat aorta by two endogenous Na/K pump inhibitors, ouabain and marinobufagenin. Evidence of interaction with different α-subunit isoforms . Am J Hypertens . 1997;10:929–935
  99. Fedorova OV , Lakatta EG , Bagrov AY . Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of DAHL rats . Circulation . 2000;102:3009–3014
  100. Bagrov AY , Feodorova OV , Dmitrieva RI , et al.   Plasma marinobufegnin-like and ouabain-like immunoreactivity during saline volume expansion in anaesthetized dogs . Cardiovasc Res . 1996;31:296–305
  101. Fedorova OV , Kolodkin NI , Agalakova NI , et al.   Marinobufagenin, an endogenous α-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats . Hypertension . 2001;37:462–466
  102. Bagrov AY , Roukayatkina NI , Fedorova OV , et al.   Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad . Eur J Pharmacol . 1993;234:165–172
  103. Fridman AI , Matveev SA , Agalakova NA , et al.   Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity . J Hypertens . 2002;20:1–6

 Supported by the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany; the Fonds der Chemischen Industrie, Frankfurt/Main, Germany; and the Akademie für Tiergesundheit, Bonn, Germany.

PII: S0270-9295(05)00053-7

doi: 10.1016/j.semnephrol.2005.03.010

Seminars in Nephrology
Volume 25, Issue 5 , Pages 343-351 , September 2005

Article Tools

* Image Usage & Resolution